Chatterjee A, Matsangos A, Latinovic O, Heredia A, Silvestri G
Arch Stem Cell Ther. 2024; 5(1):5-13.
PMID: 39301092
PMC: 11412077.
DOI: 10.46439/stemcell.5.020.
Saez-Cirion A, Mamez A, Avettand-Fenoel V, Nabergoj M, Passaes C, Thoueille P
Nat Med. 2024; 30(12):3544-3554.
PMID: 39222660
PMC: 11645271.
DOI: 10.1038/s41591-024-03277-z.
Salgado M, Galvez C, Nijhuis M, Kwon M, Cardozo-Ojeda E, Badiola J
Lancet HIV. 2024; 11(6):e389-e405.
PMID: 38816141
PMC: 11417461.
DOI: 10.1016/S2352-3018(24)00090-0.
Ni F, Hu K, Li M, Yang M, Xiao Y, Fu M
Mol Ther. 2024; 32(7):2316-2327.
PMID: 38734901
PMC: 11286811.
DOI: 10.1016/j.ymthe.2024.05.015.
Dudek A, Feist W, Sasu E, Luna S, Ben-Efraim K, Bak R
Cell Stem Cell. 2024; 31(4):499-518.e6.
PMID: 38579682
PMC: 11212398.
DOI: 10.1016/j.stem.2024.03.002.
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1.
Beschorner N, Kunzle P, Voges M, Hauber I, Indenbirken D, Nakel J
PLoS One. 2024; 19(3):e0298542.
PMID: 38457474
PMC: 10923487.
DOI: 10.1371/journal.pone.0298542.
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?.
Harper J, Betts M, Lichterfeld M, Muller-Trutwin M, Margolis D, Bar K
Pathog Immun. 2024; 8(2):115-157.
PMID: 38455668
PMC: 10919397.
DOI: 10.20411/pai.v8i2.665.
Strategies for HIV-1 suppression through key genes and cell therapy.
Sorokina A, Anchakova E, Dashinimaev E
Front Med (Lausanne). 2023; 10:1259995.
PMID: 38093984
PMC: 10716291.
DOI: 10.3389/fmed.2023.1259995.
Advances in HIV therapeutics and cure strategies: findings obtained through non-human primate studies.
Van Zandt A, MacLean A
J Neurovirol. 2023; 29(4):389-399.
PMID: 37635184
PMC: 11636591.
DOI: 10.1007/s13365-023-01162-y.
Curating evidence for a cure of HIV-1 infection by hematopoietic stem cell transplantation.
Bone B, Lichterfeld M
Med. 2023; 4(5):285-287.
PMID: 37178680
PMC: 11065144.
DOI: 10.1016/j.medj.2023.04.006.
HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.
Hsu J, Van Besien K, Glesby M, Pahwa S, Coletti A, Warshaw M
Cell. 2023; 186(6):1115-1126.e8.
PMID: 36931242
PMC: 10616809.
DOI: 10.1016/j.cell.2023.02.030.
Walk on the wild side: SIV infection in African non-human primate hosts-from the field to the laboratory.
Jasinska A, Apetrei C, Pandrea I
Front Immunol. 2023; 13:1060985.
PMID: 36713371
PMC: 9878298.
DOI: 10.3389/fimmu.2022.1060985.
Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells.
Huyveneers L, Bruns A, Stam A, Ellerbroek P, De Jong D, Nagy N
Viruses. 2022; 14(9).
PMID: 36146874
PMC: 9503691.
DOI: 10.3390/v14092069.
Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev.
Cardona M, Hinkula J, Gustafsson K, Christensson B, Wahren B, Mohamed A
Mol Biol Rep. 2022; 49(11):11187-11192.
PMID: 36098885
PMC: 9618491.
DOI: 10.1007/s11033-022-07899-9.
Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review.
Kandula U, Wake A
Biologics. 2022; 16:89-105.
PMID: 35836496
PMC: 9275675.
DOI: 10.2147/BTT.S368152.
HIV cure strategies: which ones are appropriate for Africa?.
Abana C, Lamptey H, Bonney E, Kyei G
Cell Mol Life Sci. 2022; 79(8):400.
PMID: 35794316
PMC: 9259540.
DOI: 10.1007/s00018-022-04421-z.
Epigenetic Reprogramming Leads to Downregulation of CD4 and Functional Changes in African Green Monkey Memory CD4 T Cells.
Rahmberg A, Markowitz T, Mudd J, Hirsch V, Brenchley J
J Immunol. 2022; 209(2):337-345.
PMID: 35750337
PMC: 9283288.
DOI: 10.4049/jimmunol.2200109.
Application of CRISPR/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection.
Maslennikova A, Mazurov D
Front Cell Infect Microbiol. 2022; 12:880030.
PMID: 35694537
PMC: 9177041.
DOI: 10.3389/fcimb.2022.880030.
Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies.
Ta T, Malik S, Anderson E, Jones A, Perchik J, Freylikh M
Front Microbiol. 2022; 13:862270.
PMID: 35572626
PMC: 9093714.
DOI: 10.3389/fmicb.2022.862270.
CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice.
Li S, Holguin L, Burnett J
Mol Ther Methods Clin Dev. 2022; 24:321-331.
PMID: 35229006
PMC: 8847835.
DOI: 10.1016/j.omtm.2022.01.012.
